×
About 1,579 results

ALLMedicine™ Androgen Excess Center

Research & Reviews  745 results

The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.
https://doi.org/10.1007/s12020-021-02715-z 10.1016/j.ymgme.2006.12.005 10.1038/gim.2017.46 10.1093/humupd/dmx014 10.1038/s41431-020-0653-5 10.1210/jc.2006-1645 10.1073/pnas.1300057110 10.1530/eje.0.1430397 10.1530/EC-18-0281 10.1210/jcem.86.1.7131 10.1210/jc.2008-1582 10.1055/s-0032-1330007 10.3390/ijms21134622 10.1530/EJE-20-0129 10.1016/j.mce.2016.08.014 10.1210/jc.2018-02605 10.1111/cen.12543 10.1067/mob.2000.108020 10.1210/jc.2018-01865 10.1152/physrev.00033.2015 10.1677/jme.0.0270249 10.1016/S0047-6374(01)00394-3 10.3275/7410 10.4158/EP-2018-0617 10.1159/000337217 10.1530/EJE-11-0119 10.1159/000509079 10.1530/eje.0.1360188 10.1111/apa.12147 10.1515/jpem.2007.20.8.883 10.1515/jpem-2017-0088 10.3275/8194 10.1210/jc.2012-2102 10.1530/EJE-13-0128 10.1210/jc.2002-021433 10.1159/000053253 10.1111/j.1365-2265.1995.tb01890.x 10.1111/cen.12507 10.1210/jc.2007-0744 10.1016/8756-3282(96)00003-8 10.1007/s12020-014-0332-9 10.1111/cen.14149 10.1530/EJE-07-0887 10.1159/000098017 10.1530/EJE-15-1096 10.1136/jim-2016-000085 10.1210/jc.2006-0062 10.1055/s-0034-1389901 10.1046/j.1365-2265.2000.00995.x 10.1111/nyas.13370 10.4158/EP15748.DSCPT2 10.1210/jcem-70-3-642 10.1210/jc.2009-1383 10.1210/jcem.74.3.1310999 10.1210/en.2019-00101 10.1111/jog.13288 10.1093/humrep/del284 10.1093/humrep/der126 10.1111/j.1365-2265.2009.03563.x 10.1530/EJE-11-0019 10.1530/EC-17-0094 10.1210/jc.2009-2639 10.1093/humrep/den118 10.1055/s-0035-1565183 10.1111/j.1365-2265.2010.03920.x 10.1111/cen.13429 10.1210/JC.2015-2093 10.1210/jc.2014-2957 10.4103/2230-8210.102995 10.1210/jc.2010-0917 10.1507/endocrj.51.601 10.1080/00015385.2019.1666964 10.1016/j.pharep.2019.01.014 10.1055/s-0035-1569375 10.1210/jcem.75.6.1464643 10.1159/000086363 10.1055/s-0034-1382048 10.1210/jcem.74.3.1311000 10.1055/s-0035-1549911 10.4158/EP151085.RA 10.1515/JPEM.2001.14.4.415 10.1210/jc.2014-1342 10.1159/000369901 10.1515/jpem-2016-0216 10.1210/jc.2018-00208 10.4158/EP-2019-0509 10.1007/s11136-019-02350-2 10.1007/s10508-006-9068-9 10.1007/s10508-016-0693-7 10.1016/j.jsxm.2015.11.002 10.1210/jc.2007-0556 10.1016/j.jsxm.2019.07.009 10.1016/j.psyneuen.2015.06.017 10.1210/js.2019-00122
Endocrine Ntali G, Charisis S et. al.

Apr 15th, 2021 - Females with NC21OHD may present as asymptomatic or develop a wide range of androgen excess expression. Clinical manifestations may become evident in childhood and adolescence and include premature pubarche, precocious puberty, acne, hirsutism, an...

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063257
The Journal of Clinical Endocrinology and Metabolism; Merke DP, Mallappa A et. al.

Feb 2nd, 2021 - Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. We investigated whether modified-release hydrocortisone (MR-HC), whic...

Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
https://doi.org/10.1016/j.ecl.2020.12.002
Endocrinology and Metabolism Clinics of North America; Zaman A, Rothman MS

Feb 1st, 2021 - Evidence of clinical and/or biochemical androgen excess poses a unique differential in postmenopausal women. Some signs and symptoms of postmenopausal hyperandrogenism can be normal and attributed to the natural aging process. However, the causes ...

Pharmacologic Treatments for PCOS Patients.
https://doi.org/10.1097/GRF.0000000000000597
Clinical Obstetrics and Gynecology; Kodama S, Torrealday S

Dec 21st, 2020 - Polycystic ovarian syndrome is the most common endocrinopathy in reproductive-aged women and has a vast array of clinical manifestations. Common clinical presentations of the disorder include anovulatory infertility, menstrual disorders, cutaneous...

see more →

Guidelines  11 results

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Andro...
https://doi.org/10.1210/jc.2018-02548
The Journal of Clinical Endocrinology and Metabolism; Carmina E, Azziz R et. al.

Feb 20th, 2019 - To determine the current state of knowledge and provide evidence-based recommendations that could be valid for all specialists taking care of female pattern hair loss (FPHL), a common form of hair loss in women that is characterized by the reducti...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, A...
https://doi.org/10.4158/EP15748.DSCPT2
Endocrine Practice : Official Journal of the American Col... Goodman NF, Cobin RH et. al.

Dec 7th, 2015 - Polycystic ovary syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists and the Androge...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, A...
https://doi.org/10.4158/EP15748.DSC
Endocrine Practice : Official Journal of the American Col... Goodman NF, Cobin RH et. al.

Oct 28th, 2015 - Polycystic Ovary Syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the ...

The polycystic ovary syndrome: a position statement from the European Society of Endocr...
https://doi.org/10.1530/EJE-14-0253
European Journal of Endocrinology; Conway G, Dewailly D et. al.

May 22nd, 2014 - Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The...

see more →

Clinicaltrials.gov  765 results

The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.
https://doi.org/10.1007/s12020-021-02715-z 10.1016/j.ymgme.2006.12.005 10.1038/gim.2017.46 10.1093/humupd/dmx014 10.1038/s41431-020-0653-5 10.1210/jc.2006-1645 10.1073/pnas.1300057110 10.1530/eje.0.1430397 10.1530/EC-18-0281 10.1210/jcem.86.1.7131 10.1210/jc.2008-1582 10.1055/s-0032-1330007 10.3390/ijms21134622 10.1530/EJE-20-0129 10.1016/j.mce.2016.08.014 10.1210/jc.2018-02605 10.1111/cen.12543 10.1067/mob.2000.108020 10.1210/jc.2018-01865 10.1152/physrev.00033.2015 10.1677/jme.0.0270249 10.1016/S0047-6374(01)00394-3 10.3275/7410 10.4158/EP-2018-0617 10.1159/000337217 10.1530/EJE-11-0119 10.1159/000509079 10.1530/eje.0.1360188 10.1111/apa.12147 10.1515/jpem.2007.20.8.883 10.1515/jpem-2017-0088 10.3275/8194 10.1210/jc.2012-2102 10.1530/EJE-13-0128 10.1210/jc.2002-021433 10.1159/000053253 10.1111/j.1365-2265.1995.tb01890.x 10.1111/cen.12507 10.1210/jc.2007-0744 10.1016/8756-3282(96)00003-8 10.1007/s12020-014-0332-9 10.1111/cen.14149 10.1530/EJE-07-0887 10.1159/000098017 10.1530/EJE-15-1096 10.1136/jim-2016-000085 10.1210/jc.2006-0062 10.1055/s-0034-1389901 10.1046/j.1365-2265.2000.00995.x 10.1111/nyas.13370 10.4158/EP15748.DSCPT2 10.1210/jcem-70-3-642 10.1210/jc.2009-1383 10.1210/jcem.74.3.1310999 10.1210/en.2019-00101 10.1111/jog.13288 10.1093/humrep/del284 10.1093/humrep/der126 10.1111/j.1365-2265.2009.03563.x 10.1530/EJE-11-0019 10.1530/EC-17-0094 10.1210/jc.2009-2639 10.1093/humrep/den118 10.1055/s-0035-1565183 10.1111/j.1365-2265.2010.03920.x 10.1111/cen.13429 10.1210/JC.2015-2093 10.1210/jc.2014-2957 10.4103/2230-8210.102995 10.1210/jc.2010-0917 10.1507/endocrj.51.601 10.1080/00015385.2019.1666964 10.1016/j.pharep.2019.01.014 10.1055/s-0035-1569375 10.1210/jcem.75.6.1464643 10.1159/000086363 10.1055/s-0034-1382048 10.1210/jcem.74.3.1311000 10.1055/s-0035-1549911 10.4158/EP151085.RA 10.1515/JPEM.2001.14.4.415 10.1210/jc.2014-1342 10.1159/000369901 10.1515/jpem-2016-0216 10.1210/jc.2018-00208 10.4158/EP-2019-0509 10.1007/s11136-019-02350-2 10.1007/s10508-006-9068-9 10.1007/s10508-016-0693-7 10.1016/j.jsxm.2015.11.002 10.1210/jc.2007-0556 10.1016/j.jsxm.2019.07.009 10.1016/j.psyneuen.2015.06.017 10.1210/js.2019-00122
Endocrine Ntali G, Charisis S et. al.

Apr 15th, 2021 - Females with NC21OHD may present as asymptomatic or develop a wide range of androgen excess expression. Clinical manifestations may become evident in childhood and adolescence and include premature pubarche, precocious puberty, acne, hirsutism, an...

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063257
The Journal of Clinical Endocrinology and Metabolism; Merke DP, Mallappa A et. al.

Feb 2nd, 2021 - Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. We investigated whether modified-release hydrocortisone (MR-HC), whic...

Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies.
https://doi.org/10.1016/j.ecl.2020.12.002
Endocrinology and Metabolism Clinics of North America; Zaman A, Rothman MS

Feb 1st, 2021 - Evidence of clinical and/or biochemical androgen excess poses a unique differential in postmenopausal women. Some signs and symptoms of postmenopausal hyperandrogenism can be normal and attributed to the natural aging process. However, the causes ...

Pharmacologic Treatments for PCOS Patients.
https://doi.org/10.1097/GRF.0000000000000597
Clinical Obstetrics and Gynecology; Kodama S, Torrealday S

Dec 21st, 2020 - Polycystic ovarian syndrome is the most common endocrinopathy in reproductive-aged women and has a vast array of clinical manifestations. Common clinical presentations of the disorder include anovulatory infertility, menstrual disorders, cutaneous...

see more →

News  57 results

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

Updated Guidelines on Hirsutism in Premenopausal Women
https://www.medscape.com/viewarticle/893904

Mar 13th, 2018 - An updated clinical guideline from the Endocrine Society recommends all women with hirsutism who are premenopausal should be tested for polycystic ovary syndrome (PCOS) and other underlying health issues. The guidance was published online March 7 ...

What’s in a name?
https://www.mdedge.com/familymedicine/article/145805/reproductive-endocrinology/whats-name
Clinical Endocrinology News; Michele G. Sullivan

Aug 31st, 2017 - The quest for earlier diagnosis and treatment of polycystic ovarian syndrome may be branding too many young women with an unnecessary – and emotionally burdensome – tag, experts fear. There’s little doubt that the classic phenotypes of PCOS, drive.

Androgen Excess and Cancer Risk in Infertile Women
https://www.medscape.com/viewarticle/734957

Jan 2nd, 2011 - Cancer Risk Among Infertile Women With Androgen Excess or Menstrual Disorders (Including Polycystic Ovary Syndrome) Brinton LA, Moghissi KS, Westhoff C, Lamb EJ, Scoccia B Fertil Steril. 2010;94:1787-1792 Background Reproductive hormones play a ro...

PCOS Patients' Brothers Share Metabolic Traits
https://www.mdedge.com/endocrinology/article/53056/reproductive-endocrinology/pcos-patients-brothers-share-metabolic-traits
Michele G. Sullivan

BOSTON — Brothers of women with polycystic ovary syndrome share with their sisters similar metabolic features that indicate they may be at increased risk for decreased insulin sensitivity and glucose tolerance, high triglycerides, and dyscoagulabi.

see more →

Patient Education  1 results see all →